InfuSystem Holdings (INFU) Capital Expenditures Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -47.73% |
| 10 | InfuSystem Holdings | 190.19 Mn | 188.08 Mn | 19.68 Mn | 121.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.54% |
| Dec 31, 2025 | 426.84% |
| Sep 30, 2025 | 104.77% |
| Jun 30, 2025 | 20.34% |
| Mar 31, 2025 | -93.88% |
| Dec 31, 2024 | 60.29% |
| Sep 30, 2024 | -191.49% |
| Jun 30, 2024 | 405.65% |
| Mar 31, 2024 | -218.61% |
| Dec 31, 2023 | -254.40% |
| Sep 30, 2023 | 227.90% |
| Jun 30, 2023 | 904.55% |
| Mar 31, 2023 | 673.17% |
| Dec 31, 2022 | 51.59% |
| Sep 30, 2022 | 337.93% |
| Jun 30, 2022 | -107.48% |
| Mar 31, 2022 | 2.50% |
| Dec 31, 2021 | 1,119.44% |
| Sep 30, 2021 | 59.01% |
| Jun 30, 2021 | 94.70% |